Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease
- PMID: 28672395
- PMCID: PMC5710184
- DOI: 10.1001/jamaneurol.2017.1200
Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease
Abstract
Importance: Brain hypometabolism is associated with the clinical consequences of the degenerative process, but little is known about regional hypermetabolism, sometimes observed in the brain of patients with clinically manifest Huntington disease (HD). Studying the role of regional hypermetabolism is needed to better understand its interaction with the motor symptoms of the disease.
Objective: To investigate the association between brain hypometabolism and hypermetabolism with motor scores of patients with early HD.
Design, setting, and participants: This study started in 2001, and analysis was completed in 2016. Sixty symptomatic patients with HD and 15 healthy age-matched control individuals underwent positron emission tomography to measure cerebral metabolism in this cross-sectional study. They also underwent the Unified Huntington's Disease Rating Scale motor test, and 2 subscores were extracted: (1) a hyperkinetic score, combining dystonia and chorea, and (2) a hypokinetic score, combining bradykinesia and rigidity.
Main outcomes and measures: Statistical parametric mapping software (SPM5) was used to identify all hypo- and hypermetabolic regions in patients with HD relative to control individuals. Correlation analyses (P < .001, uncorrected) between motor subscores and brain metabolic values were performed for regions with significant hypometabolism and hypermetabolism.
Results: Among 60 patients with HD, 22 were women (36.7%), and the mean (SD) age was 44.6 (7.6) years. Of the 15 control individuals, 7 were women (46.7%), and the mean (SD) age was 42.2 (7.3) years. In statistical parametric mapping, striatal hypometabolism was significantly correlated with the severity of all motor scores. Hypermetabolism was negatively correlated only with hypokinetic scores in the cuneus (z score = 3.95, P < .001), the lingual gyrus (z score = 4.31, P < .001), and the crus I/II of the cerebellum (z score = 3.77, P < .001), a region connected to associative cortical areas. More severe motor scores were associated with higher metabolic values in the inferior parietal lobule, anterior cingulate, inferior temporal lobule, the dentate nucleus, and the cerebellar lobules IV/V, VI, and VIII bilaterally corresponding to the motor regions of the cerebellum (z score = 3.96 and 3.42 in right and left sides, respectively; P < .001).
Conclusions and relevance: Striatal hypometabolism is associated with clinical disease severity. Conversely, hypermetabolism is likely compensatory in regions where it is associated with decreasing motor scores. Hypermetabolism might be detrimental in other structures in which it is associated with more severe motor symptoms. In the cerebellum, both compensatory and detrimental contributions seem to occur. This study helps to better understand the motor clinical relevance of hypermetabolic brain regions in HD.
Conflict of interest statement
Figures



Similar articles
-
Apparent relative hypermetabolism of selective brain areas in Huntington disease and importance of reference region for analysis.Clin Nucl Med. 2012 Jul;37(7):663-8. doi: 10.1097/RLU.0b013e3182478bf2. Clin Nucl Med. 2012. PMID: 22691507
-
Striatal hypometabolism in premanifest and manifest Huntington's disease patients.Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2183-2189. doi: 10.1007/s00259-016-3445-y. Epub 2016 Jun 28. Eur J Nucl Med Mol Imaging. 2016. PMID: 27349245
-
Bradykinesia in early Huntington's disease.Neurology. 2000 Jan 11;54(1):119-25. doi: 10.1212/wnl.54.1.119. Neurology. 2000. PMID: 10636136
-
Parkinsonism in Huntington's disease.Int Rev Neurobiol. 2019;149:299-306. doi: 10.1016/bs.irn.2019.10.006. Epub 2019 Nov 21. Int Rev Neurobiol. 2019. PMID: 31779817 Review.
-
The Role of the Cerebellum in Huntington's Disease: a Systematic Review.Cerebellum. 2021 Apr;20(2):254-265. doi: 10.1007/s12311-020-01198-4. Epub 2020 Oct 7. Cerebellum. 2021. PMID: 33029762
Cited by
-
The polyglutamine domain is the primary driver of seeding in huntingtin aggregation.PLoS One. 2024 Mar 14;19(3):e0298323. doi: 10.1371/journal.pone.0298323. eCollection 2024. PLoS One. 2024. PMID: 38483973 Free PMC article.
-
The Neurodevelopmental Hypothesis of Huntington's Disease.J Huntingtons Dis. 2020;9(3):217-229. doi: 10.3233/JHD-200394. J Huntingtons Dis. 2020. PMID: 32925079 Free PMC article. Review.
-
Glucose metabolic crosstalk and regulation in brain function and diseases.Prog Neurobiol. 2021 Sep;204:102089. doi: 10.1016/j.pneurobio.2021.102089. Epub 2021 Jun 10. Prog Neurobiol. 2021. PMID: 34118354 Free PMC article. Review.
-
Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients.Metabolites. 2022 Dec 6;12(12):1225. doi: 10.3390/metabo12121225. Metabolites. 2022. PMID: 36557263 Free PMC article.
-
Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington's Disease.Metabolites. 2019 Jun 11;9(6):113. doi: 10.3390/metabo9060113. Metabolites. 2019. PMID: 31212603 Free PMC article.
References
-
- Douaud G, Behrens TE, Poupon C, et al. . In vivo evidence for the selective subcortical degeneration in Huntington’s disease. Neuroimage. 2009;46(4):958-966. - PubMed
-
- Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol. 1985;44(6):559-577. - PubMed
-
- Reading SA, Dziorny AC, Peroutka LA, et al. . Functional brain changes in presymptomatic Huntington’s disease. Ann Neurol. 2004;55(6):879-883. - PubMed
-
- Antonini A, Leenders KL, Spiegel R, et al. . Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington’s disease. Brain. 1996;119(pt 6):2085-2095. - PubMed
-
- Ciarmiello A, Cannella M, Lastoria S, et al. . Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington’s disease. J Nucl Med. 2006;47(2):215-222. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical